16-1220497-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_021098.3(CACNA1H):āc.6565C>Gā(p.Pro2189Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00000518 in 1,542,930 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 32)
Exomes š: 0.0000050 ( 0 hom. )
Consequence
CACNA1H
NM_021098.3 missense
NM_021098.3 missense
Scores
6
8
5
Clinical Significance
Conservation
PhyloP100: 5.36
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant 16-1220497-C-G is Benign according to our data. Variant chr16-1220497-C-G is described in ClinVar as [Benign]. Clinvar id is 2031568.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 7 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1H | NM_021098.3 | c.6565C>G | p.Pro2189Ala | missense_variant | 35/35 | ENST00000348261.11 | NP_066921.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.6565C>G | p.Pro2189Ala | missense_variant | 35/35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000565831.6 | c.6547C>G | p.Pro2183Ala | missense_variant | 33/33 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000638323.1 | c.6526C>G | p.Pro2176Ala | missense_variant | 35/35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000569107.5 | c.2803C>G | p.Pro935Ala | missense_variant | 17/17 | 1 | ENSP00000454990.2 | |||
CACNA1H | ENST00000564231.5 | c.2755C>G | p.Pro919Ala | missense_variant | 18/18 | 1 | ENSP00000457555.2 | |||
CACNA1H | ENST00000562079.5 | c.2737C>G | p.Pro913Ala | missense_variant | 17/17 | 1 | ENSP00000454581.2 | |||
CACNA1H | ENST00000639478.1 | n.*1613C>G | non_coding_transcript_exon_variant | 35/35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.*4383C>G | non_coding_transcript_exon_variant | 35/35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000639478.1 | n.*1613C>G | 3_prime_UTR_variant | 35/35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.*4383C>G | 3_prime_UTR_variant | 35/35 | 5 | ENSP00000491488.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152048Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
152048
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000118 AC: 2AN: 169952Hom.: 0 AF XY: 0.0000108 AC XY: 1AN XY: 92984
GnomAD3 exomes
AF:
AC:
2
AN:
169952
Hom.:
AF XY:
AC XY:
1
AN XY:
92984
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000503 AC: 7AN: 1390882Hom.: 0 Cov.: 35 AF XY: 0.00000582 AC XY: 4AN XY: 687628
GnomAD4 exome
AF:
AC:
7
AN:
1390882
Hom.:
Cov.:
35
AF XY:
AC XY:
4
AN XY:
687628
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152048Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74252
GnomAD4 genome
AF:
AC:
1
AN:
152048
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74252
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 21, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;.
M_CAP
Pathogenic
D
MetaRNN
Uncertain
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;.;.;.
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;.;D;D
REVEL
Benign
Sift
Pathogenic
D;.;D;D
Sift4G
Uncertain
T;.;T;T
Polyphen
D;.;D;D
Vest4
MutPred
Loss of catalytic residue at P2189 (P = 0.0041);.;.;.;
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at